Navigation Links
Amylin Pharmaceuticals to Present New Data from Broad Diabetes and,Obesity Programs at ADA 2007

"Exenatide Maintained Glycemic Control with Associated Weight Reduction Over Three Years in Patients with Type 2 Diabetes" will be presented by John B. Buse, M.D. on Monday, June 25 at 3:15 PM CT (4:15 PM ET). 3. Poster: "Improvements in Cardiovascular Risk Factors Accompanied Improved Glycemic Control and Weight Reduction in Patients with Type 2 Diabetes Treated with Exenatide for 3.5 y" will be presented by David Kendall, M.D. during a poster session on Sunday, June 24 at 12:00 PM CT (1:00 PM ET). 4. Poster: "Pramlintide Improved Glycemic Control without Increased Risk of Hypoglycemia in Patients with Type 2 Diabetes Using Basal Insulin" will be presented by Karen Lutz, Ph.D. during a poster session on Sunday, June 24 at 12:00 PM CT (1:00 PM ET). 5. Oral: "Responsiveness to Leptin Restored by Amylin in Diet Induced Obese (DIO) Rats: Magnitude and Mechanisms of Synergy" will be presented by Jonathan Roth, Ph.D. on Monday, June 25 at 3:45 PM CT (4:45 PM ET). 6. Oral: "Sustained Weight Loss Following 1-y Pramlintide Treatment as an Adjunct to Lifestyle Intervention in Obesity" will be presented by Steven Smith, M.D. on Monday, June 25 at 5:30 PM CT (6:30 PM ET).

A full list of all Amylin abstracts being presented at ADA is available at: http://scientificsessions.diabetes.org.

    FEATURED SYMPOSIA


    1. "The Diabetes-Obesity Continuum: The Growing Body of Evidence for a

       Multihormonal Approach to Treatment."  This medical education symposium

       will help healthcare providers understand the potential of

       multihormonal treatment approaches for diabetes and obesity.  The event

       will be chaired by Carol Hatch Wysham, M.D. on Sunday, June 24 at 5:30

       AM CT (6:30 AM ET).  This symposium is supported by an
'"/>




Page: 1 2 3 4

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
Post Your Comments:
(Date:1/15/2014)... the leading health care supply chain expertise, analytics and ... national contracts that expand its portfolio to provide hospital ... These include manufacturer product and service agreements, as well ... IT consulting support. New Novation agreements ...
(Date:1/15/2014)... OAKS, Calif. , Jan. 15, 2014 ... Amgen (NASDAQ: AMGN ) announced today ... jointly discover and validate new therapeutic targets and ... a chronic disorder that affects millions worldwide. The ...
(Date:1/15/2014)...  Humberto C. Antunes,  Galderma  worldwide CEO, will receive a ... of Drugs in Dermatology (JDD) at the upcoming ... is January 17-20, 2014, at the Omni Orlando Resort at ChampionsGate ... The ODAC is a distinguished event that delivers a ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
(Date:4/18/2014)... French . ... medicine. A team led by Ludwik Leibler from the ... Didier Letourneur from the Laboratoire Recherche Vasculaire Translationnelle (INSERM/Universits ... the principle of adhesion by aqueous solutions of nanoparticles ... and tissues. This easy-to-use gluing method has been tested ...
(Date:4/17/2014)... have identified new pain relief targets that could ... BBSRC-funded researchers at King,s College London made the ... in the periphery of the body. , Dr ... identifying mechanisms underlying pain generation and our findings ... side effects." , One potential side effect of ...
(Date:4/17/2014)... (April 17, 2014) Two recent papers by ... and colleagues may help scientists develop treatments or ... fever, Japanese encephalitis and other disease-causing flaviviruses. , ... and molecular genetics at the School of Medicine ... Hughes Medical Institute, and colleagues recently published articles ...
(Date:4/17/2014)... 2014) Doctors who treat patients with a ... can face an agonizing treatment decision. , The ... and help relieve shortness of breath. But some ... can cause potentially fatal complications following transplantation. , ... Dilling, medical director of Loyola University Medical Center,s ...
(Date:4/17/2014)... BostonResearchers from Boston University School of Medicine (BUSM) ... alcohol consumption in an experimental model. The findings, ... and Alcohol Abuse , may lead to more ... alcohol is one of the leading causes of ... significant negative economic impact by limiting the productivity ...
Breaking Medicine News(10 mins):Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:New pain relief targets discovered 2Health News:CU researchers discover target for treating dengue fever 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2
... Elderly People Suffering From CHF, COPD, Diabetes and, ... More Effective With a New, Interactive Telehealth ... NOERRESUNDBY, Denmark, May 19 RTX Healthcare,today announced ... telehealth,monitors, which allows healthcare system integrators and disease ...
... now available in Lexi-Comp(R) ONLINE(TM), providing ... information on diseases and disorders, ... leading,provider of drug reference information, now offers Harrison,s Practice, ... conditions. Harrison,s Practice, developed by McGraw-Hill,Professional, a leading global ...
... United States today are now much more likely to be ... of kidney cancer than a decade ago, leading to a ... national study led by a UC San Diego Medical Center ... UC San Diego Medical Center and the Moores UCSD Cancer ...
... Many patients may soon find relief from the ... bowel syndrome, or IBS. , Lubiprostone, known by the ... Food and Drug Administration for use in women with ... Michigan Health System research that demonstrated the safety and ...
... to advance, device enables deeper enteroscopy, SAN ... ), a leading developer of diagnostic and therapeutic,advancement ... Week 2008 that it has received 510(k) clearance ... with its Endo-Ease Discovery SB,device in endoscopic procedures., ...
... openings avoids incisions, shortens recoveries , , SUNDAY, May ... may lead to painless and scar-free surgery with ... laparoscopic surgery, U.S. studies suggest. , Called ... is inserted through a natural body opening, rather ...
Cached Medicine News:Health News:RTX Healthcare Launch Wireless Telehealth Monitor With Built-in GSM/GPRS Mobile Phone Technology 2Health News:Lexi-Comp, Inc. Offers Diagnosis and Disease Management Tool 2Health News:Lexi-Comp, Inc. Offers Diagnosis and Disease Management Tool 3Health News:Majority of kidney cancers diagnosed at earliest stage 2Health News:Drug brings relief for many IBS patients who experience constipation 2Health News:Spirus Medical Announces 510(k) Clearance from FDA for Expanded Use of Endo-Ease(R) Discovery SB(TM) 2Health News:New Surgical Technology Holds Promise of Painless, Scarless Procedures 2Health News:New Surgical Technology Holds Promise of Painless, Scarless Procedures 3
... neurophysiological monitoring system has been designed ... the needs of the ever changing ... collection and analyzing data from multiple ... EMG, EEG and multiple patients at ...
... Inc. is the largest independently ... to ophthalmic surgical instrumentation. Katena ... 7,000 customers in the United ... network of distributors, to customers ...
... Studies have proven that the management of diabetes ... glucose levels is the most effective way to ... care aimed at maintaining or improving a diabetes ... and costly. , ,These have been the ...
... is intended for detecting trends and tracking ... 18 and older) and children/adolescents (aged 7 ... the use of the G2 Biographer with ... to supplement, not replace, conventional blood glucose ...
Medicine Products: